Lilly's Retatrutide Achieves Biggest Weight Loss in Trial History, Outpacing Current GLP-1 Drugs and Surgery
A new triple-hormone drug shows clinical results that could reshape obesity treatment and reduce demand for invasive bariatric surgery, potentially lowering costs and expanding access to effective weight management.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap "Open original source" above to read their full reporting and support the contributing newsroom directly.
Related stories
Why it mattersThe EWG reports that only 20% of sunscreens meet safety standards. Image Credit: Ani Dimi/Stocksy Only about 20% of sunscreens meet leading safety and efficacy standards, according to a recent report from the Environment…
The EWG reports that only 20% of sunscreens meet safety standards. Image Credit: Ani Dimi/Stocksy Only about 20% of sunscreens meet leading safety and efficacy …
By Chella·11h ago
No comments yet. Be the first.